Literature DB >> 8477148

Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type.

L Parnetti1, G Abate, L Bartorelli, D Cucinotta, M Cuzzupoli, M Maggioni, C Villardita, U Senin.   

Abstract

A multicentre, randomised, controlled study compared the efficacy of l-alpha-glyceryl-phosphorylcholine (alpha GPC) and ST200 (acetyl-l-carnitine) among 126 patients with probable senile dementia of Alzheimer's type (SDAT) of mild to moderate degree. Efficacy was evaluated by means of behavioural scales and psychometric tests. The results showed significant improvements in most neuropsychological parameters in the alpha GPC recipients. Improvements also occurred in the ST200 recipients but to a lesser extent. Tolerability was good in both groups. These positive findings require replication in larger, double-blind, longitudinal studies coupling clinical and biological determinations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477148     DOI: 10.2165/00002512-199303020-00006

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  8 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

Authors:  R I Shader; J S Harmatz; C Salzman
Journal:  J Am Geriatr Soc       Date:  1974-03       Impact factor: 5.562

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  A new rating scale for dementia syndromes.

Authors:  C G Gottfries; G Bråne; G Steen
Journal:  Gerontology       Date:  1982       Impact factor: 5.140

5.  Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.

Authors:  G Rai; G Wright; L Scott; B Beston; J Rest; A N Exton-Smith
Journal:  Curr Med Res Opin       Date:  1990       Impact factor: 2.580

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

8.  A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia.

Authors:  R Di Perri; G Coppola; L A Ambrosio; A Grasso; F M Puca; M Rizzo
Journal:  J Int Med Res       Date:  1991 Jul-Aug       Impact factor: 1.671

  8 in total
  7 in total

Review 1.  Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.

Authors:  M Simard; R van Reekum
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  Complementary and alternative medicines in the treatment of dementia: an evidence-based review.

Authors:  Bruce Diamond; Susan Johnson; Kathleen Torsney; Jennifer Morodan; Brian Prokop; Dana Davidek; Patricia Kramer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholine.

Authors:  L Ferraro; S Tanganelli; L Marani; C Bianchi; L Beani; A Siniscalchi
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

4.  Effect of Acetyl-L-carnitine Used for Protection of Neonatal Hypoxic-Ischemic Brain Injury on Acute Kidney Changes in Male and Female Rats.

Authors:  Andrew G Wang; Michele Diamond; Jaylyn Waddell; Mary C McKenna
Journal:  Neurochem Res       Date:  2019-04-30       Impact factor: 3.996

5.  Multiple forms of the enzyme glycerophosphodiesterase are present in human brain.

Authors:  B M Ross; A L Sherwin; S J Kish
Journal:  Lipids       Date:  1995-12       Impact factor: 1.880

Review 6.  Acetyl-L-carnitine for dementia.

Authors:  S Hudson; N Tabet
Journal:  Cochrane Database Syst Rev       Date:  2003

7.  Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data.

Authors:  Minjae Kang; Dan Bee Lee; Sungchan Kwon; Eun Lee; Woo Jung Kim
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.